US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT07585968 N/A
Recruiting
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System f...
Condition
Ventricular Tachycardia
Enrollment
260 pts
Location
United States
Sponsor
Medtronic Cardiac Ablation Sol
View Trial →
NCT03945162 Phase 2
Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Mus...
Condition
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Enrollment
90 pts
Location
United States, Canada
Sponsor
Theralase® Technologies Inc.
View Trial →
NCT07341503 N/A
Recruiting
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarke...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
100 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT05893888 Phase 2, Phase 3
Recruiting
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subj...
Condition
Oral Squamous Cell Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
Privo Technologies
View Trial →
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Pa...
Condition
Ovarian Cancer
Enrollment
334 pts
Location
United States, Belgium, Germany
Sponsor
Gilead Sciences
View Trial →
NCT06608966 N/A
Recruiting
Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
Condition
Epilepsy in Children
Enrollment
310 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT06492122 Phase 1
Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
50 pts
Location
United States, Australia, China
Sponsor
Full-Life Technologies UK Limi
View Trial →
NCT06022029 Phase 1
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in ...
Condition
Triple Negative Breast Cancer
Enrollment
168 pts
Location
United States, Australia
Sponsor
OncoNano Medicine, Inc.
View Trial →
NCT06466122 Phase 2
Recruiting
Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL o...
Condition
Chronic Lymphocytic Leukemia
Enrollment
30 pts
Location
United States
Sponsor
Kerry Rogers
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT07232602 Phase 1, Phase 2
Recruiting
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortu...
Condition
Bladder Cancer
Enrollment
55 pts
Location
United States, Chile, France
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06193954 N/A
Recruiting
VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chr...
Condition
Chronic Total Occlusion of Coronary Artery
Enrollment
10 pts
Location
United States
Sponsor
VasoStar, LLC
View Trial →
NCT07717554 N/A
Recruiting
Effect of Virtual Yoga in Diabetic Gastroparesis Patients
Condition
Diabetic Gastroparesis
Enrollment
240 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT07554521 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Lo...
Condition
Advanced Unresectable Gastric Adenocarcinoma
Enrollment
30 pts
Location
United States
Sponsor
BeOne Medicines
View Trial →
NCT06556693 N/A
Recruiting
Janus II Feasibility
Condition
Sleep Apnea
Enrollment
40 pts
Location
United States
Sponsor
Zoll Medical Corporation
View Trial →
NCT07092540 N/A
Recruiting
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in t...
Condition
Duchenne Muscular Dystrophy (DMD)
Enrollment
105 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT07017010 N/A
Recruiting
Optimizing Phonological Awareness Learning in Prekindergarten and Kindergarten t...
Condition
Reading Difficulties
Enrollment
720 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
View Trial →
NCT06379789 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX G...
Condition
Hemophilia B
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07738978 N/A
Recruiting
Understanding and Enhancing Human Health and Movement
Condition
Spinal Cord Injury
Enrollment
75 pts
Location
United States
Sponsor
Louis Stokes VA Medical Center
View Trial →
Page 3 of 19 — 475 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology